10.3389/fnagi.2019.00088 Front
The "rapid reversal" group (approximately 10-15% of users) experiences concerning quick benefit loss within weeks of discontinuation, typically involving users who applied very high concentrations creating dependency-like patterns, possessed severe underlying skin conditions requiring ongoing treatment, experienced significant lifestyle or environmental stressors overwhelming skin resilience, discontinued abruptly without tapering from high-dose protocols, or had unrealistic perception inflation during treatment leading to exaggerated reversal perception
Tesamorelin is primarily prescribed for HIV-related lipodystrophy and has a more targeted effect on reducing visceral fat
Clinical data show that nausea, vomiting, and gastrointestinal upset occur across all GLP-1 classes, but frequency and severity differ by person, formulation, and titration schedule
However, this technique is impractical in the clinical setting and it is mostly used for research purposes
Gibco), 500 L of N-2 nutrient (Gibco), 1 mL of B-27 Supplement (Gibco), 50 L of the small molecule inhibitor LDN-193189 (final concentration, 100 ng/mL